
Is there a place for AI art? These Hong Kong artists say yes
In spite of an open letter signed by over 6,500 artists, demanding the cancellation of Augmented Intelligence – Christie's
artificial intelligence (AI) art auction that ran from February 20 to March 5 – the event was a commercial success, bringing in more than US$728,000, with 28 of the 34 displayed pieces sold.
The letter, written to auction hosts Nicole Sales Giles and Sebastian Sanchez, stated: 'Many of the artworks you plan to auction were created using AI models that are known to be trained on copyrighted work without a licence. These models … exploit human artists, using their work without permission or payment to build commercial AI products that compete with them.
'Your support of these models … rewards and further incentivises AI companies' mass theft of human artists' work.'
This work by Bianca Tse used AI to generate an impression of the Kowloon Walled City in Hong Kong. Photo: Handout
But it should be said that not all artists are against the use of AI – there are those in Hong Kong
who fully embrace it and even make it their primary creative medium. Bianca Tse, for instance, believes there is a lot of misunderstanding surrounding AI art and the technology behind it. For example, high-profile artists like Refik Anadol, whose work was featured in the auction, train their models using their own work or data sets, where the copyright claims should 'clearly' belong to the artist.
'My understanding of commercial AI models is that they don't target specific artists' works, but are trained on vast data sets comprising trillions of images from various sources,' Tse explains. 'The AI learns to imagine and create – much like how a human artist learns by observing and interpreting the world around them.'
Tse, who graduated from the Hong Kong Polytechnic University School of Design, says her big turning point came when she stopped seeing AI as a threat and started viewing it as a 'powerful creative partner'.
Liza Dorrer. Photo: Handout
Liza Dorrer, who is completing her PhD at the Hong Kong University of Science and Technology (HKUST), and teaches specialised courses on AI image-generation tools Midjourney and Stable Diffusion for interior designers and architects, believes that the debate on whether AI art is 'real' art comes down to the technology behind the tools.
Hashtags

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles


South China Morning Post
34 minutes ago
- South China Morning Post
China's firms invest more efficiently when facing ‘trade shocks': researchers
Chinese firms tend to invest more efficiently when facing higher duties or import restrictions, according to a study that highlights an unexpected benefit of tariffs by analysing data from before the two trade wars with the United States. Published in the peer-reviewed Journal of Corporate Finance, the paper examined more than 2,700 listed firms in China, their financial and accounting data from 2003 to 2016, and the trade barriers imposed on the country during this period. The paper was released in April when Chinese exporters faced renewed trade turbulence, with the world's two largest economies imposing triple-digit tariffs on each other – before agreeing to a 90-day truce in May. The European Union has also levied anti-subsidy duties on Chinese electric vehicles. Trade defence instruments (TDIs), such as anti-dumping or countervailing duties, have largely prompted Chinese companies to allocate capital more effectively, according to the paper. This was especially true for cash-rich firms that lacked strong governance, where unchecked investments had been more common. 'Our findings reveal a nuanced dynamic, showing that trade protection measures, such as TDIs, can have complex and counterintuitive effects on target firms' resource allocation and the broader economy.' The authors called trade shocks an 'external disciplining mechanism' that reduces free cash flow and curbs overinvestment, where excessive resources are poured into underperforming projects.


South China Morning Post
an hour ago
- South China Morning Post
More investor attention coming to China advancements in AI, humanoid tech: Morgan Stanley
China's advancements in artificial intelligence (AI) and humanoid technology will continue to capture the imaginations of investors as the world turns its focus to the region, according to Morgan Stanley 's director of pan-Asia research. Advertisement 'The DeepSeek announcement has shifted the fundamental discussion about China to technological innovation,' said Magdalena Stoklosa in an interview last month. 'This theme is multi-year and incredibly important.' Her team identified technological diffusion and the spread of AI across economies as key long-term research themes. AI start-up DeepSeek's breakthroughs earlier this year in large-language models sparked a rally in Chinese stocks. In February, the US investment bank upgraded Chinese stocks to equal weight from underweight, due to improving valuations and a significant shift towards new-economy companies. 'We still see that China is underweight from a perspective of global emerging markets positioning and it should effectively be at least close,' Stoklosa said. Advertisement Over the next 12 to 18 months, she said it was important to keep an eye on how various AI models work, spread through the economy and become monetised. 'In China, the discussion is layered with government support for AI infrastructure, a thriving innovation scene with start-ups, mega industry players, and a strategic push to build open-source models that make access to AI quicker and more affordable for many corporations,' she added.


South China Morning Post
an hour ago
- South China Morning Post
Mainland Chinese market for weight loss and diabetes drugs to soon be more crowded: report
Competition in the mainland Chinese market for diabetes and weight loss drugs is set to intensify as more than 60 late-stage drug candidates are undergoing clinical trials, according to a recent report. Up to 20 biosimilar or generic copies will vie for market share and add pricing pressure after Denmark-based Novo Nordisk's semaglutide product loses patent protection in China next year, according to Boston-based global consultancy L.E.K. Consulting. Novo Nordisk's patent will expire in 2031 in Japan and Europe and 2032 in the US, according to its latest annual report. 'The landscape in China is expected to become even more competitive than in developed markets, where the GLP-1 category is primarily dominated by leading multinational pharmaceutical companies,' said Helen Chen, L.E.K.'s global healthcare and life sciences co-head, in a report on May 15. GLP-1 drugs mimic natural hormones, which signal the pancreas to release more insulin when blood-sugar levels are high, and also support weight loss by slowing digestion and reducing appetite. 04:12 One reporter's weight-loss journey and what a 'healthy body' means to him One reporter's weight-loss journey and what a 'healthy body' means to him Driven by sales growth of semaglutide, Novo Nordisk became the 10th largest drug company in the world in terms of revenue. London-based consultancy Evaluate said the firm's revenue rose 25 per cent to US$42.1 billion last year.